Disc Medicine Inc’s recent filing unveils that its Director White William Richard unloaded Company’s shares for reported $81407.0 on Apr 11 ’24. In the deal valued at $31.80 per share,2,560 shares were sold. As a result of this transaction, White William Richard now holds 0 shares worth roughly $0.0.
Then, Bitterman Kevin sold 26,157 shares, generating $1,922,540 in total proceeds. Upon selling the shares at $73.50, the Director now owns 677,503 shares.
Before that, Bitterman Kevin sold 102,500 shares. Disc Medicine Inc shares valued at $6,934,125 were divested by the Director at a price of $67.65 per share. As a result of the transaction, Bitterman Kevin now holds 198,326 shares, worth roughly $5.94 million.
Raymond James downgraded its Disc Medicine Inc [IRON] rating to an Outperform from a a Strong buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid December from “an Overweight” to “an Equal-weight”. Raymond James also remained covering IRON and has increased its forecast on June 09, 2023 with a “Strong buy” recommendation from previously “an Outperform” rating. H.C. Wainwright started covering the stock on June 07, 2023. It rated IRON as “a Buy”.
Price Performance Review of IRON
On Tuesday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -1.93% to $29.93. Over the last five days, the stock has lost -6.70%. Disc Medicine Inc shares have fallen nearly -48.18% since the year began. Nevertheless, the stocks have risen 36.36% over the past one year. While a 52-week high of $77.60 was reached on 03/04/24, a 52-week low of $21.70 was recorded on 04/01/24. SMA at 50 days reached $57.38, while 200 days put it at $53.76. A total of 0.29 million shares were traded, compared to the trading of 0.39 million shares in the previous session.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 29.37, which if violated will result in even more drops to 28.81. On the upside, there is a resistance level at 30.98. A further resistance level may holdings at 32.02. The Relative Strength Index (RSI) on the 14-day chart is 23.34, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.87, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.33%. Stochastics %K at 13.91% indicates the stock is a buying.
The most recent change occurred on May 17, 2023 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.
